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Summary
Two-thirds of cases of tuberous sclerosis complex (TSC)
are sporadic and usually are attributed to new muta-
tions, but unaffected parents sometimes have more than
one affected child. We sought to determine how many
of these cases represent germ-line mosaicism, as has been
reported for other genetic diseases. In our sample of 120
families with TSC, 7 families had two affected children
and clinically unaffected parents. These families were
tested for mutations in the TSC1 and TSC2 genes, by
Southern blotting and by single-strand conformational
analysis. Unique variants were detected in six families.
Each variant was present and identical in both affected
children of a family but was absent in both parents and
the unaffected siblings. Sequencing of the variants
yielded two frameshift mutations, one missense muta-
tion, and two nonsense mutations in TSC2 and one non-
sense mutation in TSC1. To determine which parent
contributed the affected gametes, the families were an-
alyzed for linkage to TSC1 and TSC2, by construction
of haplotypes with markers flanking the two genes. Link-
age analysis and loss-of-heterozygosity studies indicated
maternal origin in three families, paternal origin in one
family, and either being possible in two families. To eval-
uate the possibility of low-level somatic mosaicism for
TSC, DNA from lymphocytes of members of the six
families were tested by allele-specific PCR. In all the
families, the mutant allele was detected only in the
known affected individuals. We conclude that germ-line
mosaicism was present in five families with mutations
in the TSC2 gene and in one family with the causative
mutation in the TSC1 gene. The results have implica-
tions for genetic counseling of families with seemingly
sporadic TSC.
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Introduction
Tuberous sclerosis complex (TSC) is an autosomal dom-
inant disease with a prevalence as high as 1/6,000 (Os-
borne et al. 1991). One-third of cases are familial; two-
thirds of cases are sporadic and are attributed to new
mutations (Sampson et al. 1989; Osborne et al. 1991).
Two causative genes have been identified and cloned:
TSC1 at 9q34.3 (MIM 191100) and TSC2 at 16p13.3
(MIM 191092) (The European Chromosome 16 Tuber-
ous Sclerosis Consortium 1993; van Slegtenhorst et al.
1997). TSC has variable expressivity and is thought to
be highly penetrant. Fifteen families with two or more
affected children and apparently unaffected parents have
been reported and are thought to illustrate examples of
germ-line mosaicism (Lowry et al. 1979; Osborne et al.
1991; Northrup et al. 1993; Ruggieri et al. 1997). Yates
et al. (1997) have proved germ-line mosaicism for TSC2
in one family, by molecular analysis. Germ-line mosai-
cism has been reported for many other genetic diseases,
such as osteogenesis imperfecta type II (Byers et al. 1988)
and Duchenne muscular dystrophy (Edwards 1986), as
well as for disorders associated with malignant changes,
such as retinoblastoma (Sippel et al. 1997), Von Hip-
pel–Lindau disease (Murgia et al. 1997), and neurofi-
bromatosis type I (Lazaro et al. 1994). In addition, so-
matic mosaicism has been reported for TSC (Verhoef et
al. 1995; Sampson et al. 1997).
Unaffected parents who have had a child affected with
TSC usually are given a low (1%) recurrence risk. Ev-
idence that germ-line mosaicism is not an uncommon
phenomenon would increase the estimated risk in cases
of sporadic TSC and, thus, would have implications for
genetic counseling. The goal of this study was to deter-
mine germ-line mosaicism in seven families with unaf-
fected parents and two affected siblings, by linkage stud-
ies and mutation analysis. We also evaluated the parents
for low-level somatic mosaicism in their lymphyocytes.
Subjects and Methods
Family Studies
In our sample of 120 families with TSC, we catego-
rized 82 as sporadic (one affected child and unaffected
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Table 1
Epidemiological Data and Medical Evaluation of Parents
FAMILY
AND PARENT
AGE (IN YEARS) OF














Mother 21 33 N N N N
Father 21 33 N N N N
HOU-21:
Motherb 27 45 N N N N
Father 27 45 N N N N
HOU-23:
Motherb 20 21 N ) ) )
Father 27 28 N ) ) )
HOU-28:
Mother 27 31 N ) ) )
Father 27 31 N ) ) )
HOU-33:
Mother 27 31 N N N )
Fatherb 31 35 N N N )
HOU-34:
Mother 29 32 N N ) )
Father 32 35 N N ) )
HOU-37:
Motherb 26 34 N N N N
a Medical and diagnostic evaluation of unaffected parents of affected children. Both parents were
examined in all families, except family HOU-37, in which only the mother of the two half siblings was
evaluated. The parents of family HOU-23 declined further testing: at the time of this study, the mother
was 57 years of age, and the father was 64 years of age; neither had any findings consistent with TSC.
N  normal result. An ellipsis ()) indicates that the test was not performed.
b Parent who contributed the mutated gamete.
parents), 32 as multigenerational (multiple affected in-
dividuals in a family with autosomal dominant inheri-
tance), and 7 as possibly representing examples of germ-
line mosaicism (two affected children and unaffected
parents). TSC diagnoses were reached in accordance
with standard diagnostic criteria (Gomez 1991; Roach
et al. 1992). The parents of all sporadic patients were
examined carefully for TSC, with the exception of the
father in family HOU-37, who is deceased. No findings
consistent with TSC were detected. Some parents un-
derwent additional clinical testing, including retinal ex-
amination, renal ultrasonography, and/or computed to-
mography or a magnetic-resonance–imaging scan of the
brain. During the course of the study, one family initially
categorized as sporadic, on the basis of lack of clinical
findings in the parents, was reassigned into the category
of families with germ-line mosaicism, after the birth of
a second affected child. These families included six sets
of full sibs and one set of half sibs. Family history was
negative for any findings suggestive of TSC, for all seven
families. Parental ages at the birth of the affected chil-
dren and results of diagnostic studies are summarized in
table 1. The study was approved by the institutional
review board at the University of Texas Medical School–
Houston.
Linkage Studies for Chromosomes 9 and 16
Five markers that flank TSC1 on 9q34.3 were tested:
D9S149, D9S2127, D9S1199, D9S1198, and D9S150
(van Slegtenhorst et al. 1997). Four markers that flank
TSC2 on 16p13.3 were tested: D16S525, TSC2EcoRV,
KG8, and D16S665. TSC2EcoRV is an RFLP within the
TSC2 gene, and KG8 is located at the 3′ end of TSC2
(Au et al. 1997b). All markers, except TSC2EcoRV, were
tested by PCR amplification followed by electrophoresis
on a sequencing gel. TSC2EcoRV was tested by PCR
amplification, enzyme digestion, and electrophoresis on
an agarose gel.
Southern Blotting, PCR, Single-Strand Conformational
Analysis (SSCA), and Direct Sequencing
Southern blotting, PCR, and SSCA were performed as
described elsewhere (Au et al. 1997b). Allele-specific
PCR was performed as described by Kaltenbock and
Schneider (1998), with the following modifications: an-
nealing temperatures were 10C lower than the calcu-
lated melting temperatures of the allele-specific primers,
and 21 thermal cycles were used for amplification. Direct
sequencing was performed by the Molecular Genetics
Core Facility, Department of Microbiology and Molec-
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Figure 1 Haplotype analysis of pedigrees. Paternal haplotypes are boxed, and maternal haplotypes are within ovals. a,HOU-21. Mosaicism
in the father was excluded because the two affected siblings have inherited different paternal alleles. The mother gave the same chromosome
to all the children, which is consistent with her having germ-line mosaicism. b, HOU-23. On the basis of the haplotype analysis, either parent
could have germ-line mosaicism; however, LOH studies indicated that the mother is the parent with mosaicism. c, HOU-28. Either parent could
have germ-line mosaicism. d, HOU-33. The father gave the same chromosome 16 to both affected children but not to the unaffected children,
indicating that he is the parent with mosaicism. The mother was excluded because she gave opposite haplotypes to the affected children. e,
HOU-34. Either parent could have germ-line mosaicism. f, HOU-37. The mother has germ-line mosaicism.
ular Genetics, at the University of Texas Medical
School–Houston. The families were tested for mutations
in the TSC1 and TSC2 genes. TSC2 was evaluated by
Southern blotting. TSC1 and TSC2 were screened exon
by exon, by use of SSCA. To determine which parent
contributed the affected gametes, we analyzed the fam-
ilies for linkage to TSC1 and TSC2 by constructing hap-
lotypes, using markers flanking the two genes (fig. 1).
Results
No gross deletions or rearrangements in TSC2 were
detected by Southern blotting. Unique variants were de-
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tected, by SSCA, in six families. Each variant was present
and identical in both affected children of a family but
was absent in both parents and the unaffected siblings
(fig. 2). Sequencing of variants yielded two frameshift
mutations, one missense mutation, and two nonsense
mutations in TSC2 and one nonsense mutation in TSC1
(table 2). With the exception of the missense mutation,
these mutations are predicted to cause premature ter-
mination of the gene products (tuberin and hamartin).
Linkage analysis indicated maternal origin in two fam-
ilies, paternal origin in one family, and either being pos-
sible in three families. In family HOU-23, angiomyo-
lipoma tissue was available from the two affected
individuals. The results of loss-of-heterozygosity (LOH)
studies of the tumors were positive for five of eight tu-
mors (Au et al. 1997a). The results of LOH and linkage
studies indicated that the paternal allele was lost (data
not shown). We therefore concluded that the maternal
allele harbored the mutation.
Although the parents had none of the findings of TSC,
on physical examination or by radiological testing, we
performed additional testing to evaluate the possibility
of somatic mosaicism for TSC. DNA from lymphocytes
of all members of the six nuclear families in which a
mutation was detected was tested for low-level mosai-
cism, by allele-specific PCR. In all families, the mutant
allele was detected only in the known affected individ-
uals. Although the parents may have somatic mosaicism,
its absence in lymphocytic DNA in these families ex-
cludes that tissue as an easy source for diagnostic
purposes.
A mutation has not been identified in one family.
Exon-by-exon screening of TSC1 and TSC2 was nega-
tive. We have not exhausted all possibilities for the de-
tection of mutation in this family, because SSCA is
predicted to detect only ∼70% of variants. Furthermore,
we did not test the promoters and the intronic sequences,
which also could harbor mutations.
Discussion
Germ-line mosaicism has been demonstrated in both
common and uncommon genetic disorders (Hall 1988).
Because most germ-line mutations are likely to be mitotic
in origin and because the mutation rate multiplied by
the number of mitoses necessary to form the gametes is
11 (van der Meulen et al. 1995), germ-line mosaicism
would be expected to occur to some degree in all genetic
disorders. Empiric recurrence risks of specific diseases
can be estimated, but risks for individual families depend
on the percentage of affected gametes in the germ line
of the parent with mosaicism.
We suspected, on the basis of clinical findings, that
germ-line mosaicism was present in 6% (7/120) of the
families in our study. Five of the seven families have more
than two children. In three of these five families, if the
parents had chosen to limit the family size to two chil-
dren, we would never have suspected germ-line mosai-
Figure 2 Detection of variant bands (arrows) in affected children. Variant bands were not seen in the parents or the unaffected siblings.
HOU-21 (a) had variant bands in exon 8 of TSC1, HOU-23 (b) in exon 24 of TSC2, HOU-28 (c) in exon 33b of TSC2, HOU-33 (d) in exon
22 of TSC2, HOU-34 (e) in exon 13 of TSC2, and HOU-37 (f) in exon 16 of TSC2.
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Table 2
Mutations in TSC1 and TSC2 in Families with Germ-Line Mosaism
Family Gene Exon Sequence Change Codon Change
HOU-21 TSC1 8 C682T R228X
HOU-23 TSC2 24 2779insC P928 FSrX939
HOU-28 TSC2 33b C4186T Q1396X
HOU-33 TSC2 22 2638delA Ag K880 FSrX909
HOU-34 TSC2 13 C1372T R458X
HOU-37 TSC2 16 C1831T R611W
NOTE.—One mutation in TSC1 and five mutations in TSC2 were
found in six families with mosaicism. Three families (HOU-21, HOU-
28, and HOU-34) had nonsense mutations, two families (HOU-23 and
HOU-33) had frameshift mutations, and one family (HOU-37) had a
missense mutation.
cism in one of the parents. Many parents chose not to
have additional children after the birth of a child affected
with TSC, because of the large burden of the seizures
(80% of patients) and mental retardation (50% of
patients) caused by the disease. Owing to the small size
of the families in this study, coupled with the general
trend toward smaller family size in developed countries,
the frequency of germ-line mosaicism for mutations in
the TSC genes is difficult to predict.
With the availability of the TSC1 and TSC2 genes,
we were able to determine the molecular basis for germ-
line mosaicism in six of the seven suspected families. We
have shown that germ-line mosaicism can result from
mutations in either TSC1 or TSC2 and in either parent
of a family. We conclude that germ-line mosaicism that
results in TSC is not rare and that a percentage of cases
currently categorized as sporadic may actually represent
germ-line mosaicism. Unfortunately, despite our best ef-
forts to determine recurrence risks by all clinical means
available, we cannot predict which families have a parent
with germ-line mosaicism. Molecular diagnosis does not
solve the problem. We recommend counseling a conser-
vative recurrence risk of 2%–3% for families with ap-
parently sporadic TSC.
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